摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

16-oximino-estrone | 6038-23-9

中文名称
——
中文别名
——
英文名称
16-oximino-estrone
英文别名
(8R,9S,13S,14S,16Z)-3-hydroxy-16-hydroxyimino-13-methyl-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-one
16-oximino-estrone化学式
CAS
6038-23-9
化学式
C18H21NO3
mdl
——
分子量
299.37
InChiKey
IRFSYLYJKJQLIR-GDSFRMMZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    22
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    69.9
  • 氢给体数:
    2
  • 氢受体数:
    4

SDS

SDS:2f23f94e20b56969419cef7202306a6c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    16-oximino-estrone盐酸羟胺sodium acetate 作用下, 以 甲醇 为溶剂, 以52%的产率得到16,17-bis-oximino-estrone
    参考文献:
    名称:
    [EN] 17BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS
    [FR] COMPOSE
    摘要:
    公开号:
    WO2004085457A3
  • 作为产物:
    描述:
    雌酚酮氢化钾叔丁醇亚硝酸异戊酯溶剂黄146 作用下, 以 为溶剂, 反应 3.0h, 以63%的产率得到16-oximino-estrone
    参考文献:
    名称:
    [EN] 17BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS
    [FR] COMPOSE
    摘要:
    公开号:
    WO2004085457A3
点击查看最新优质反应信息

文献信息

  • [EN] STEROIDAL COMPOUNDS FOR INHIBITING STEROID SULPHATASE<br/>[FR] COMPOSE
    申请人:STERIX LTD
    公开号:WO2003033518A1
    公开(公告)日:2003-04-24
    There is provided a compound having Formula (I) wherein G is H or a substituent, and wherein R1 is any one of a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group, capable of inhibiting steroid sulphatase.
    提供了一种具有化学式(I)的化合物,其中G是氢或取代基,R1是能够抑制类固醇硫酸酯酶的磺酰胺基团、膦酸酯基团、硫代膦酸酯基团、磺酸基团或磺酰胺基团中的任意一种。
  • Steroidal compounds for inhibiting steroid sulphatase
    申请人:Potter Victor Lloyd Barry
    公开号:US20050014776A1
    公开(公告)日:2005-01-20
    There is provided a compound having Formula (I) wherein G is H or a substituent, and wherein R 1 is any one of a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group, capable of inhibiting steroid sulphatase.
    提供了一种具有公式(I)的化合物,其中G为H或取代基,其中R1为硫酰胺基团、膦酸基团、硫代膦酸基团、磺酸基团或磺酰胺基团中的任意一种,能够抑制类固醇硫酸酯酶。
  • Compound
    申请人:Vicker Nigel
    公开号:US20060074060A1
    公开(公告)日:2006-04-06
    There is provided a compound of Formula (I) wherein (I) R2 is selected from (i) an alkyloxyalkyl group (ii) a nitrile group, and wherein R2 is capable of forming a hydrogen bond (iii) alkylaryl group, wherein the aryl group is substituted by other than a C1-10 group (iv) alkenylaryl group wherein the aryl group is substituted (v) alkylheteroaryl group, wherein when heteroaryl group comprises only C and N in the ring, the aryl group is substituted by other than a methyl group (vi) alkenylheteroaryl group, (vii) ═N—O-alkyl or ═N—O—H group (viii) branched alkenyl (ix) alkyl-alcohol group (x) amide or alkylamide wherein (a) the alkyl of the alkylamide is —CH2— or —Ch2Ch2—, (b) the amide is di-substituted and/or (c) the amide is substituted with at least one of alkyl heterocycle group, alkenyl heterocycle group, alkylheteroaryl group, alkenylheteroaryl group, heteroaryl group, alkylamine group, alkyloxyalkyl group, alkylaryl group, straight or branched alkyl group, (xi) —CHO so that R1 together with R3 provide the enol tautomer (a); OR R2 together with R3 form (xii) a pyrazole wherein (a) R4 is ═N—O-alkyl or ═N—O—H group, (b) the pyrazole is substituted with one of alkyl-OH group, alkyl ester group, alkyloxyalkyl group, branched alkyl group, and an amide and/or (c) the 2 position is substituted with a group selected from —OH and —O-hydrocarbyl (xiii) a heteroaryl ring to provide a compound of the formula (b); (II) R2 is selected from groups capable of forming a hydrogen bond, a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group and a sulphonamide group; and (III) R3 is selected from —OH, ═O, or a C(═O)—mimetic.
    提供了一个化合物的公式(I),其中(I) R2选自(i)烷氧基烷基,(ii)腈基,且R2能够形成氢键,(iii)烷基芳基,其中芳基被取代,除了C1-10基团,(iv)烯基芳基,其中芳基被取代,(v)烷基杂芳基,其中杂芳基仅包含C和N,芳基被取代,除了甲基基团,(vi)烯基杂芳基,(vii) ═N—O-烷基或═N—O—H基团,(viii)支链烯基,(ix)烷基醇基团,(x)酰胺或烷基酰胺,其中(a)烷基酰胺的烷基是—CH2—或—Ch2Ch2—,(b)酰胺是二取代的和/或(c)酰胺被取代,至少有一个是烷基杂环基团,烯基杂环基团,烷基杂芳基,烯基杂芳基,杂芳基,烷基胺基,烷氧基烷基,烷基芳基,直链或支链烷基,(xi) —CHO,使得R1与R3提供烯醇互变异构体(a);或R2与R3形成(xii)吡唑,其中(a)R4是═N—O-烷基或═N—O—H基团,(b)吡唑被取代,其中取代基是烷基-OH基团,烷基酯基团,烷氧基烷基,支链烷基和酰胺,和/或(c)2位被取代,所选的基团是—OH和—O-烃基,(xiii)杂芳环,以提供公式(b)的化合物;(II) R2选自能够形成氢键,磺酰胺基团,膦酸盐基团,硫代磷酸盐基团,磺酸盐基团和磺酰胺基团的基团;(III) R3选自—OH,═O或C(═O)-类似物。
  • Steroidal Compounds For Inhibiting Steroid Sulphatase
    申请人:Potter Barry Victor Lloyd
    公开号:US20080312266A1
    公开(公告)日:2008-12-18
    There is provided a compound having Formula (I) wherein G is H or a substituent, and wherein R 1 is any one of a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group, capable of inhibiting steroid sulphatase.
    提供了一种化合物,其化学式为(I),其中G为氢或取代基,R1为磺酰胺基团、膦酸基团、硫代膦酸基团、磺酸基团或磺酰胺基团中的任意一种,能够抑制类固醇硫酸酯酶。
  • 17beta-hydroxysteroid dehydrogenase inhibitors
    申请人:Sterix Limited
    公开号:EP2336146A1
    公开(公告)日:2011-06-22
    There is provided a compound of Formula I wherein (I) R1 is a selected from (i) an alkyloxyalkyl group (ii) a nitrile group, and wherein R2 is capable of forming a hydrogen bond (iii) alkylaryl group, wherein the aryl group is substituted by other than a C1-10 group (iv) alkenylaryl group wherein the aryl group is substituted (v) alkylheteroaryl group, wherein when heteroaryl group comprises only C and N in the ring, the aryl group is substituted by other than a methyl group (vi) alkenylheteroaryl group, (vii) =N-O-alkyl or =N-O-H group (viii) branched alkenyl (ix) alkyl-alcohol group (x) amide or alkylamide wherein (a) the alkyl of the alkylamide is - CH2- or -CH2CH2-, (b) the amide is di-substituted and/or (c) the amide is substituted with at least one of alkylheterocycle group, alkenylheterocycle group, alkylheteroaryl group, alkenylheteroaryl group, heteroaryl group, alkylamine group, alkyloxyalkyl group, alkylaryl group, straight or branched alkyl group, (xi) -CHO so that R1 together with R3 provide the enol tautomer OR R1 together with R3 form (xii) a pyrazole wherein (a) R4 is =N-O-alkyl or =N-O-H group, (b) the pyrazole is substituted with one of alkyl-OH group, alkyl ester group, alkyloxyalkyl group, branched alkyl group, and an amide and/or (c) the 2 position is substituted with a group selected from -OH and -O-hydrocarbyl (xiii) a heteroaryl ring to provide a compound of the formula (II) R2 is selected from groups capable of forming a hydrogen bond , a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group and a sulphonamide group; and (III)R3 is selected from -OH, =O, or a -C(=O)- mimetic
    提供了一种式 I 的化合物 其中(I)R1选自(i)烷氧基烷基(ii)腈基,其中R2能形成氢键(iii)烷芳基,其中芳基被C1-10基团以外的基团取代(iv)烯芳基,其中芳基被取代(v)烷基杂芳基,其中当杂芳基在环中仅包括C和N时,芳基被甲基以外的基团取代(vi)烯基杂芳基、(vii) =N-O-烷基或 =N-O-H-基团 (viii) 支链烯基 (ix) 烷醇基 (x) 酰胺或烷酰胺,其中 (a) 烷酰胺的烷基是-CH2-或-CH2CH2-,(b) 酰胺是二取代的和/或 (c) 酰胺被烷基杂环基团中的至少一个取代、烯基杂环基团、烷基杂芳基基团、烯基杂芳基基团、杂芳基基团、烷基胺基团、烷氧基烷基基团、烷芳基基团、直链或支链烷基基团中的至少一个被取代; (xi) -CHO,这样 R1 与 R3 一起提供烯醇同分异构体 (xii) 吡唑,其中 (a) R4 为 =N-O- 烷基或 =N-O-H 基团,(b) 吡唑被烷基-OH 基团、烷基酯基团、烷氧基烷基基团、支链烷基基团和酰胺中的一个基团取代,和/或 (c) 2 位被选自-OH 和-O-氢羰基的基团取代 (xiii) 杂芳基环,提供式中化合物 (II) R2 选自能形成氢键的基团、氨基磺酸基、膦酸基、硫代磷酸基、磺酸基和磺酰胺基; (III) R3 选自-OH、=O 或-C(=O)-模拟基。
查看更多